← FDA Drug Approvals (Drugs@FDA)

POTASSIUM CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT · Approved 2024-02-06

Drug application

FDA Application #

ANDA213986

Application type

Abbreviated New Drug Application (Generic)

Brand name

POTASSIUM CITRATE

Generic name

Potassium Citrate

Active ingredients

POTASSIUM CITRATE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

TORRENT

First approval

2024-02-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown